Skip to main content

Table 1 Participant characteristics

From: Disparities in access to food and chronic obstructive pulmonary disease (COPD)-related outcomes: a cross-sectional analysis

 

Food deserta (N = 604)

Non-food deserta (N = 2109)

p Value

FEV1% pred., mean ± SD

71.7 ± 27.2

73.4 ± 26.3

0.159

COPD (Strata 3 & 4)b, %

64.2

66.9

0.230

Age, mean ± SD

60.6 ± 8.8

64.3 ± 8.8

 < 0.001

Female, %

50.2

44.9

0.021

White, %

61.8

80.9

 < 0.001

Some college or above, %

44.9

59.4

 < 0.001

Income, %

  

 < 0.001

 Under $15,000, %

30.8

17.2

 

 $15,000–$34,999, %

24.0

17.7

 

 $35,000–$49,999, %

11.5

12.7

 

 $50,000–$74,999, %

11.8

15.0

 

 > $75,000, %

8.0

19.5

 

Decline to answer, %

13.8

18.0

 

Married, %

35.6

50.0

 < 0.001

Nonrural, %

98.3

86.2

 < 0.001

BMI, %

28.3 ± 5.6

27.8 ± 5.2

0.064

Currently Smoking, %

54.1

36.0

 < 0.001

Pack years, mean ± SD

47.6 ± 32.8

49.8 ± 25.0

0.082

Low income tract, %

100.0

23.1

 < 0.001

Low food access, %

100.0

55.5

 < 0.001

  1. Data are given as percentages unless otherwise indicated
  2. Bold values indicate statistical significance at the p < 0.05 level
  3. aFood desert refers to areas defined as both low food access and low income tracts. Low food access refers to a census tract with at least 500 people or 33 percent of the population living more than 1/2 mile (urban areas) or 10 miles (rural areas) from the nearest supermarket, supercenter, or large grocery store. Low income tract refers to a census tract where the tract's poverty rate is 20 percent or greater, or the tract's median family income is less than or equal to 80% of the State-wide median family income, or the tract is in a metropolitan area and has a median family income less than or equal to 80 percent of the metropolitan area's median family income
  4. bStratum 3 includes participants with > 20 pack-years and mild/moderate COPD with FEV1 /FVC < 0.7 and FEV1 > 50% predicted (GOLD stage 1 and 2) measured during enrollment. Stratum 4 includes participants with > 20 pack-years and severe COPD with FEV1 /FVC < 0.7 and FEV1 < 50% predicted (GOLD stage 3 and 4) measured during enrollment [24]